News Update: Regeneron Pharmaceuticals, Inc. To Release Data On Late-Stage Drug Trials

News Update: Regeneron Pharmaceuticals, Inc. to Release Data on Late-Stage Drug Trials

Regeneron Covid-19 'antibody cocktail' drug enters late-stage trials

CNBC Television

Regeneron aims for COVID-19 drug trials by early summer

CNBC Television

Regeneron Shares Slide as FDA Puts Drug Study on Hold

Regeneron's science chief on starting clinical trials for Covid-19 antibody drug

CNBC Television

Coronavirus: Regeneron, Sanofi release preliminary results for Kevzara drug trial

CNBC Television

Regeneron stock surges on positive results in eye disease drug trial

Regeneron's Antibody Drug Helps Prevent COVID-19 For Up To 8 Months, Company Trial Results Show

Regeneron president on Covid antibody cocktail efficacy and supply chain

CNBC Television

Regeneron antibody drug shown to prevent symptomatic Covid-19

CNBC Television

Regeneron launches US clinical trials to treat severe COVID-19 symptoms

CNBC Television

Regeneron reports positive results on initial data for Covid-19 antibody drug

CNBC Television

Regeneron reports antibody drug lowers risk of medical visits by 57%

CNBC Television

Regeneron's Antibody Drug Helps Prevent COVID-19 For Up To 8 Months, Company Trial Results Show

Regeneron co-founder on the race for a coronavirus treatment

CNBC Television

Coronavirus: Developing a therapy for preventing and fighting the outbreak, Regeneron says

CNBC Television

Regeneron receives $450 million federal contract for Covid-19 antibody drug

CNBC Television

What is Regeneron's antibody cocktail? Here's what we know about Trump's treatment

Antibody Drug Regeneron Enters Clinical Trials At UM

Regeneron Clinical Trials In Colorado Leave Some Optimistic